SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-002287
Filing Date
2022-02-28
Accepted
2022-02-28 16:07:57
Documents
15
Period of Report
2022-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dvax-20220228.htm   iXBRL 8-K 48755
2 EX-99.1 dvax-ex99_1.htm EX-99.1 422920
3 GRAPHIC img191369596_0.jpg GRAPHIC 119568
4 GRAPHIC img191369596_1.jpg GRAPHIC 119568
  Complete submission text file 0000950170-22-002287.txt   936698

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dvax-20220228.xsd EX-101.SCH 2501
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dvax-20220228_pre.xml EX-101.PRE 9589
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dvax-20220228_lab.xml EX-101.LAB 12936
9 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20220228_htm.xml XML 4540
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 22689411
SIC: 2834 Pharmaceutical Preparations